These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27868226)

  • 1. Factors affecting patient reporting of adverse drug reactions: a systematic review.
    Al Dweik R; Stacey D; Kohen D; Yaya S
    Br J Clin Pharmacol; 2017 Apr; 83(4):875-883. PubMed ID: 27868226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.
    Inch J; Watson MC; Anakwe-Umeh S
    Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of patient reporting to the pharmacovigilance system: a systematic review.
    Inácio P; Cavaco A; Airaksinen M
    Br J Clin Pharmacol; 2017 Feb; 83(2):227-246. PubMed ID: 27558545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK.
    de Vries ST; Denig P; Andrić A; Dimov Di Giusti M; Ptaszynska-Neophytou A; Härmark L; Mol PGM;
    Drug Saf; 2021 Oct; 44(10):1073-1083. PubMed ID: 34368940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
    Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
    Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' experiences on adverse drug reactions reporting: a qualitative study.
    Al Dweik R; Yaya S; Stacey D; Kohen D
    Eur J Clin Pharmacol; 2020 Dec; 76(12):1723-1730. PubMed ID: 32661571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
    Hariraj V; Aziz Z
    Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
    Adisa R; Adeniyi OR; Fakeye TO
    Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme.
    Hazell L; Cornelius V; Hannaford P; Shakir S; Avery AJ;
    Drug Saf; 2013 Mar; 36(3):199-206. PubMed ID: 23444232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions, practices and barriers to reporting of adverse drug reactions among HIV infected patients and their doctors in 3 public sector hospitals of the Ethekwini Metropolitan, Kwa-Zulu Natal: a cross sectional and retrospective analysis.
    Zondi S; Naidoo P
    BMC Health Serv Res; 2022 Aug; 22(1):1054. PubMed ID: 35982442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.
    van Hunsel F; van der Welle C; Passier A; van Puijenbroek E; van Grootheest K
    Eur J Clin Pharmacol; 2010 Nov; 66(11):1143-50. PubMed ID: 20658130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
    Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
    Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study-study protocol.
    Dweik RA; Yaya S; Stacey D; Kohen D
    Springerplus; 2016; 5():213. PubMed ID: 27026907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting, handling, and subjective importance of adverse drug reactions among general practitioners: an exploratory cross-sectional survey.
    Gahr M; Connemann B; Zeiss R; Schönfeldt-Lecuona C; Dreyhaupt J; Lazik C
    Expert Opin Drug Saf; 2021 Aug; 20(8):979-985. PubMed ID: 34014779
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors associated with underreporting of adverse drug reactions by patients: a systematic review.
    Costa C; Abeijon P; Rodrigues DA; Figueiras A; Herdeiro MT; Torre C
    Int J Clin Pharm; 2023 Dec; 45(6):1349-1358. PubMed ID: 37247159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.